IDIOPATHIC INTRACRANIAL HYPERTENSION IN A WOMAN WITH SCHIZOPHRENIA

Idiopathic intracranial hypertension (IIH) or benign intracranial hypertension is a neurological syndrome characterized by elevated intracranial pressure. This uncommon disorder occurs primarily in obese women aged 10 to 50 years, sometimes in association with endocrine and metabolic dysfunction, wi...

Full description

Bibliographic Details
Main Authors: Ivan N. Dimitrov, Alexandra J. Tzoukeva, Nadezhda S. Deleva, Ara G. Kaprelyan
Format: Article
Language:English
Published: Peytchinski Publishing 2012-02-01
Series:Journal of IMAB
Subjects:
Online Access:http://www.journal-imab-bg.org/issue-2012/book1/JofIMAB2012vol18b1p206-208.pdf
_version_ 1818956311735304192
author Ivan N. Dimitrov
Alexandra J. Tzoukeva
Nadezhda S. Deleva
Ara G. Kaprelyan
author_facet Ivan N. Dimitrov
Alexandra J. Tzoukeva
Nadezhda S. Deleva
Ara G. Kaprelyan
author_sort Ivan N. Dimitrov
collection DOAJ
description Idiopathic intracranial hypertension (IIH) or benign intracranial hypertension is a neurological syndrome characterized by elevated intracranial pressure. This uncommon disorder occurs primarily in obese women aged 10 to 50 years, sometimes in association with endocrine and metabolic dysfunction, with systemic diseases or when treated with multiple medications. We describe a case of IIH in a 43-year-old woman with schizophrenia treated with risperidone, demonstrating a typical clinical picture of benign intracranial hypertension. For the 5 years of treatment with risperidone she put on 35 kg in total (BMI> 35); for the last 2-3 months she began to complain of visual obscurations, nausea with vomiting. Ophthalmoscopy revealed bilateral asymmetric papilledema (OD>OS). Magnetic resonance imaging was normal, intracranial pressure was elevated IIH was diagnosed. Risperidone was discontinued and replaced with Seroquel 200 mg daily. Treatment with furosemide and mannitol 10 % was initiated. Papilledema resolved completely over the next 2 months. The patient was followed-up for four years after risperidone withdrawal. Weight loss of 28 kg was noted for four years. There were no relapses of headache, nausea, visual obscuration. Ophthalmologic examination revealed no papilledema.We suggest that prolonged use of antipsychotics, such as risperidone, should require proper surveillance for possible development of IIH and routine ophthalmologic examinations should be performed.
first_indexed 2024-12-20T10:51:57Z
format Article
id doaj.art-9082c01555934bd1aa11cbb9c49b81c6
institution Directory Open Access Journal
issn 1312-773X
language English
last_indexed 2024-12-20T10:51:57Z
publishDate 2012-02-01
publisher Peytchinski Publishing
record_format Article
series Journal of IMAB
spelling doaj.art-9082c01555934bd1aa11cbb9c49b81c62022-12-21T19:43:14ZengPeytchinski PublishingJournal of IMAB1312-773X2012-02-01181206208IDIOPATHIC INTRACRANIAL HYPERTENSION IN A WOMAN WITH SCHIZOPHRENIAIvan N. DimitrovAlexandra J. TzoukevaNadezhda S. DelevaAra G. KaprelyanIdiopathic intracranial hypertension (IIH) or benign intracranial hypertension is a neurological syndrome characterized by elevated intracranial pressure. This uncommon disorder occurs primarily in obese women aged 10 to 50 years, sometimes in association with endocrine and metabolic dysfunction, with systemic diseases or when treated with multiple medications. We describe a case of IIH in a 43-year-old woman with schizophrenia treated with risperidone, demonstrating a typical clinical picture of benign intracranial hypertension. For the 5 years of treatment with risperidone she put on 35 kg in total (BMI> 35); for the last 2-3 months she began to complain of visual obscurations, nausea with vomiting. Ophthalmoscopy revealed bilateral asymmetric papilledema (OD>OS). Magnetic resonance imaging was normal, intracranial pressure was elevated IIH was diagnosed. Risperidone was discontinued and replaced with Seroquel 200 mg daily. Treatment with furosemide and mannitol 10 % was initiated. Papilledema resolved completely over the next 2 months. The patient was followed-up for four years after risperidone withdrawal. Weight loss of 28 kg was noted for four years. There were no relapses of headache, nausea, visual obscuration. Ophthalmologic examination revealed no papilledema.We suggest that prolonged use of antipsychotics, such as risperidone, should require proper surveillance for possible development of IIH and routine ophthalmologic examinations should be performed.http://www.journal-imab-bg.org/issue-2012/book1/JofIMAB2012vol18b1p206-208.pdfIdiopathic intracranial hypertensionBenign intracranial hypertensionRisperidoneWeight gainSchizophrenia.
spellingShingle Ivan N. Dimitrov
Alexandra J. Tzoukeva
Nadezhda S. Deleva
Ara G. Kaprelyan
IDIOPATHIC INTRACRANIAL HYPERTENSION IN A WOMAN WITH SCHIZOPHRENIA
Journal of IMAB
Idiopathic intracranial hypertension
Benign intracranial hypertension
Risperidone
Weight gain
Schizophrenia.
title IDIOPATHIC INTRACRANIAL HYPERTENSION IN A WOMAN WITH SCHIZOPHRENIA
title_full IDIOPATHIC INTRACRANIAL HYPERTENSION IN A WOMAN WITH SCHIZOPHRENIA
title_fullStr IDIOPATHIC INTRACRANIAL HYPERTENSION IN A WOMAN WITH SCHIZOPHRENIA
title_full_unstemmed IDIOPATHIC INTRACRANIAL HYPERTENSION IN A WOMAN WITH SCHIZOPHRENIA
title_short IDIOPATHIC INTRACRANIAL HYPERTENSION IN A WOMAN WITH SCHIZOPHRENIA
title_sort idiopathic intracranial hypertension in a woman with schizophrenia
topic Idiopathic intracranial hypertension
Benign intracranial hypertension
Risperidone
Weight gain
Schizophrenia.
url http://www.journal-imab-bg.org/issue-2012/book1/JofIMAB2012vol18b1p206-208.pdf
work_keys_str_mv AT ivanndimitrov idiopathicintracranialhypertensioninawomanwithschizophrenia
AT alexandrajtzoukeva idiopathicintracranialhypertensioninawomanwithschizophrenia
AT nadezhdasdeleva idiopathicintracranialhypertensioninawomanwithschizophrenia
AT aragkaprelyan idiopathicintracranialhypertensioninawomanwithschizophrenia